Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2003
10/01/2003CN1446095A Animal papilla disinfectants and method for improving microbial environment which harmful to animal
10/01/2003CN1446053A Food supplement
10/01/2003CN1445357A Dog meat wine for tonifying the kidney and its preparing technique
10/01/2003CN1445356A Mutton strong tonic wine and its preparing technique
10/01/2003CN1444991A Preparing method and usage of cardiotoxin
10/01/2003CN1444988A External plaster of sea horse and soft-shelled turtle
10/01/2003CN1444950A Technique for preparing granules of ÔÇÿfrog oilÔÇÖ"
10/01/2003CN1122719C Modified biological material
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/01/2003CN1122536C Method for purifying blood plasma and apparatus suitable therefor
10/01/2003CN1122531C Method for industrially producing Japanese encephalitis vaccine, and resulting vaccine
10/01/2003CN1122527C Medicine for curing prostatosis and preparation process
10/01/2003CN1122526C Medicine for treating hepatitis B and preparation method thereof
10/01/2003CN1122525C Medicine for treating gastropathy and preparation process thereof
10/01/2003CN1122524C Chinese medicine for treating diabetes and its preparing process
10/01/2003CN1122522C Medicine for treating dipression mental diseases
10/01/2003CN1122520C Capsule for treating femoral head necrosis
10/01/2003CN1122517C Capsule for treating epilepsy
10/01/2003CN1122516C Medicine for treating oral and throat disease
10/01/2003CN1122515C Frozen dry powder of sheep placenta
09/2003
09/30/2003US6627738 No-modified hemoglobins and uses therefor
09/30/2003US6627230 Method of preparing a bone product by removing cancellous bone matrix
09/30/2003US6627229 Viricide comprising an active ingredient of a calcium-containing substance such as oyster shell; safely, inexpensively prevents food poisoning
09/30/2003US6627213 Administering on the same day the infant is fed human breast milk a supplement free of carbohydrate and comprising casein, salts of casein, whey, and casein hydrolysates; decrease of jaundice and increase of excretion of bilirubin
09/30/2003US6627191 Viable for at least 14 days in culture without replication or differentiation
09/30/2003US6627190 Telomerase resistance; anticancer agents
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/25/2003WO2003078610A1 A method for generating human nervous system cells, tissues, or neural stem cell progenitors from haematopoietic stem cells
09/25/2003WO2003078609A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078608A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003WO2003078607A2 Tissue specific signal-plexes to dedifferentiate and redifferentiate cells
09/25/2003WO2003078597A2 Tissue engineering
09/25/2003WO2003078592A2 Method for the purification, production and formulation of oncolytic adenoviruses
09/25/2003WO2003078588A2 Primitive and proximal hepatic stem cells
09/25/2003WO2003078586A2 Vascularized tissue for transplantation
09/25/2003WO2003078568A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
09/25/2003WO2003078567A2 Methods of inducing differentiation in ex vivo expanded stem cells
09/25/2003WO2003078023A1 Compound removal device
09/25/2003WO2003077965A1 Polymer composition loaded with cells
09/25/2003WO2003077937A1 Pharmaceutical compositions comprising mannose binding lectin
09/25/2003WO2003077933A1 Increasing tumor oxygen content by administration of stressed cells
09/25/2003WO2003077865A2 Methods and compositions for directing cells to target organs
09/25/2003WO2003077864A2 Methods and compositions for directing cells to target organs
09/25/2003WO2003077859A2 Method of inducing an enhanced immune response against hiv
09/25/2003WO2003077852A2 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β
09/25/2003WO2003077840A2 Method of modulating inflammatory response
09/25/2003WO2003077829A2 Process for preparation of a pharmaceutical composition containing acid labile compounds
09/25/2003WO2003068171A3 Method and composition for treatment of inflammation and aids-associated neurological disorders
09/25/2003WO2003040368A3 Pharmaceutical compositions of marine sponge microciona prolifera
09/25/2003WO2003035879A3 Promoters to control cell differentiation
09/25/2003WO2003031643A9 Methods for regulating co-stimulatory molecule expression with reactive oxygen
09/25/2003WO2003022988A3 Adipose-derived stem cells and lattices
09/25/2003WO2003013577A3 Use of il-18 inhibitors in hypersensitivity disorders
09/25/2003WO2003012078A3 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
09/25/2003WO2003011331A3 Materials and methods relating to improved vaccination strategies
09/25/2003WO2002100827A9 Method for increasing the survival of dopamine secreting cells
09/25/2003WO2002097066A3 Human vascular progenitor cells
09/25/2003WO2002092826A3 Composition and method for treating cancer using herpes virus
09/25/2003WO2002046419A3 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
09/25/2003US20030181661 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
09/25/2003US20030181659 Thrombopoietin receptor modulating peptide
09/25/2003US20030181362 Receptor
09/25/2003US20030181358 Use a high-molecular-weight extracellular haemoglobin as a blood substitute
09/25/2003US20030180947 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
09/25/2003US20030180943 Method of culturing human chondrocytes
09/25/2003US20030180936 Method for the purification, production and formulation of oncolytic adenoviruses
09/25/2003US20030180934 Plasminogen-like polynucleotides, polypeptides, and antibodies
09/25/2003US20030180880 Chromosome 1 gene and gene products related to alzheimer's disease
09/25/2003US20030180799 Antibodies against plasma cells
09/25/2003US20030180785 Polynucleotide molecules encoding Neospora proteins
09/25/2003US20030180762 Mild enrichment of foetal cells from peripheral blood and use thereof
09/25/2003US20030180755 Pharmaceutical compositions in particulate form
09/25/2003US20030180706 Removal of prions from blood, plasma and other liquids
09/25/2003US20030180705 Introducing a cell-fluid containing vascular endothelial precursor cell and cells to be removed into a cell separator which allows the cells to be removed to pass through but captures the precursor cells
09/25/2003US20030180331 Facilitation of wound healing with CM101/GBS toxin
09/25/2003US20030180326 Methods and compositions for impairing multiplication of HIV-1
09/25/2003US20030180318 Composition having anticancer activity
09/25/2003US20030180294 Administering vascular endothelial growth factor receptor inhibitor; supression lymphangiogenesis
09/25/2003US20030180288 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
09/25/2003US20030180274 Skin disorders; bone defects; administering mixture of blood platelet and calcium phosphate
09/25/2003US20030180273 Microorganisms for treatment or prevention of corpulence and diabetes mellitus, and pharmaceutical composition containing the same
09/25/2003US20030180272 Probiotics in primary prevention of atopic diseases
09/25/2003US20030180271 Reduce concentration of (mono or di)saccharide absorbed by human body; forming polysaccharides in presence of microorganism
09/25/2003US20030180269 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
09/25/2003US20030180268 Cell differentiation on a three-dimensional, biocompatible support
09/25/2003US20030180266 Methods of expressing LIM mineralization protein in non-osseous cells
09/25/2003US20030180265 Modulating angiogenesis
09/25/2003US20030180264 Using catheter or stent; in situ tissue transfer
09/25/2003US20030180260 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
09/25/2003US20030180181 Methods for sterilizing tissue
09/25/2003DE10214095C1 Producing dedifferentiated, programmable stem cells of human monocytic origin using culture medium having M-CSF and IL-3, useful in treating cirrhosis, pancreatic insufficiency, kidney failure, cardiac infarction and stroke
09/25/2003CA2519623A1 Increasing tumor oxygen content by administration of stressed cells
09/25/2003CA2488928A1 Method of modulating inflammatory response
09/25/2003CA2479679A1 Methods of inducing differentiation in ex vivo expanded stem cells
09/25/2003CA2479510A1 Primitive and proximal hepatic stem cells
09/25/2003CA2479152A1 Methods of inducing differentiation of stem cells into a specific cell lineage
09/25/2003CA2479042A1 Cartilage regeneration using chondrocyte and tgf-.beta.
09/25/2003CA2478766A1 Polymer composition loaded with cells
09/25/2003CA2478651A1 Method of inducing an enhanced immune response against hiv
09/25/2003CA2477946A1 Compound removal device
1 ... 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 ... 1259